Newleos Therapeutics
A new dawn for treatment of mental health conditions - Newleos
United States · $93.5M raised
- Business Model
- B2B
- Website
- newleos.com
- Total Funding
- $93.5M
- Last Round
- $93.5M Series AFeb 2025
- Rounds
- 1
About
Newleos Therapeutics is a clinical-stage biotech company developing therapies for mental health conditions, co-founded by Longwood Fund.
Summary
Newleos Therapeutics is a Biotech company based in United States. It has raised $93.5M in total across 1 round, most recently a $93.5M Series A round in Feb 2025. Investors include Goldman Sachs Alternatives, Novo Holdings A/S and Longwood Fund.
Tech & App Stack
5 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Feb 2025
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...